Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Feb 2024. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
5304849011 | Product containing only dapagliflozin and saxagliptin in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
5304850011 | Dapagliflozin and saxagliptin only product in oral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing only dapagliflozin and saxagliptin in oral dose form (medicinal product form) | Is a | Product containing only dapagliflozin and saxagliptin (medicinal product) | true | Inferred relationship | Some | ||
Product containing only dapagliflozin and saxagliptin in oral dose form (medicinal product form) | Is a | Product containing dapagliflozin and saxagliptin in oral dose form (medicinal product form) | true | Inferred relationship | Some | ||
Product containing only dapagliflozin and saxagliptin in oral dose form (medicinal product form) | Has manufactured dose form | Oral dose form | true | Inferred relationship | Some | ||
Product containing only dapagliflozin and saxagliptin in oral dose form (medicinal product form) | Plays role | Antidiabetic therapeutic role (role) | false | Inferred relationship | Some | ||
Product containing only dapagliflozin and saxagliptin in oral dose form (medicinal product form) | Has active ingredient | Saxagliptin (substance) | true | Inferred relationship | Some | 1 | |
Product containing only dapagliflozin and saxagliptin in oral dose form (medicinal product form) | Has active ingredient | Dapagliflozin (substance) | true | Inferred relationship | Some | 2 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Product containing precisely dapagliflozin (as dapagliflozin propanediol) 10 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each conventional release oral tablet (clinical drug) | Is a | True | Product containing only dapagliflozin and saxagliptin in oral dose form (medicinal product form) | Inferred relationship | Some |
This concept is not in any reference sets